Stocks
Stock market analysis, company news, and equity insights
300 articles
Latest News
Stitch Fix (SFIX) Q4 2026 Financial Results Summary
Stitch Fix (SFIX) Q4 2026: Revenue Growth but Client Decline — Cautiously Optimistic Stitch Fix, Inc. (NASDAQ: SFIX) reported its fourth quarter and full fiscal year 2026 financial results, revealing a mixed performance. The company achieved net revenue of $324.4 million, marking an increase of...
Aytu BioPharma (AYTU) Q4 2026 Financial Results Summary
Aytu BioPharma (AYTU) Q4 2026: Revenue Growth Amidst Challenges — Cautiously Optimistic Aytu BioPharma reported its fourth quarter fiscal 2026 results, revealing a net revenue increase of $1.0 million or +6.4% year-over-year, rising to $16.1 million from $15.1 million in the prior-year quarter....
Worthington Enterprises (WOR) Q1 2027 Financial Results Summary
Worthington Enterprises (WOR) Q1 2027: Strong Growth in Sales and Earnings — Positive Outlook Worthington Enterprises Inc. (NYSE: WOR) reported its first quarter fiscal 2027 results, showcasing a robust performance compared to the prior year. The company achieved net sales of $343.9 million, an...
KB Home (KBH) T 2026 Financial Results Summary
KB Home (KBH) Q3 2026: Revenue Decline Amid Market Challenges — Disappointing Quarter KB Home (NYSE: KBH) reported its third-quarter results for 2026, revealing a significant decline in revenue and earnings compared to the previous year. Specifically, revenues fell by $323 million or 20%...
Abivax SA (ABVX) H1 2026 Financial Results
Abivax (ABVX) Q1 2026: Significant Net Loss Increase — Disappointing Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) reported a net loss of €165.9 million for the first half of 2026, an increase of €65.1 million or +64.5% compared to a net loss of €100.8 million in the same period...
Anaptys (ANAB) Q2 2026 Financial Results Summary
AnaptysBio (ANAB) Q2 2026: Strong Growth in Jemperli Sales — Positive Outlook AnaptysBio, Inc. (Nasdaq: ANAB) reported its financial results for the second quarter and transitional fiscal year ended June 30, 2026, showcasing a significant increase in revenue driven by Jemperli sales. The company...
Aeluma (ALMU) Q4 2026 Financial Results Summary
Aeluma, Inc. (ALMU) Q4 2026: Revenue Decline and Increased Losses — Disappointing Quarter Aeluma, Inc. (NASDAQ: ALMU) reported its fourth quarter and full fiscal year 2026 financial results, revealing a significant decline in revenue and an increase in net losses compared to the previous year....
Lennar Corporation (LEN) Financial Results Summary
Lennar Corporation (LEN) Q3 2026: Earnings Decline Amid Market Challenges — Disappointing Quarter Lennar Corporation (NYSE: LEN) reported its third-quarter results for 2026, revealing a significant decline in earnings compared to the previous year. Net earnings attributable to Lennar were $284...
Nasdaq 100 Bull & Bear Radar — September 16, 2026
A daily technical sweep of 100 Nasdaq 100 constituents ranked by session performance, enriched with RSI, MA20/MA50/MA200 trend signals, Bloomberg-style…
S&P 500 Bull & Bear Radar — September 16, 2026
A daily technical sweep of 492 S&P 500 constituents ranked by session performance, enriched with RSI, MA20/MA50/MA200 trend signals, Bloomberg-style…
Nasdaq 100 52-Week Highs & Lows Radar: Fortinet (FTNT), PepsiCo (PEP) and more
Nasdaq 100 stocks nearest to their 52-week high and low. Bloomberg-style charts, RSI/MA analysis and Grok commentary.
S&P 500 52-Week Highs & Lows Radar: Thermo Fisher Scientific (TMO), McDonald's (MCD) and more
S&P 500 stocks nearest to their 52-week high and low. Bloomberg-style charts, RSI/MA analysis and Grok commentary.
Nasdaq 100 2026 YTD Highs & Lows Radar: Crowdstrike (CRWD), Synopsys, (SNPS) and more
Nasdaq 100 stocks nearest to their 2026 year-to-date high and low. Bloomberg-style charts, RSI/MA analysis and Grok commentary.
TOPS (TOPS) H1 2025 Financial Results
TOP Ships Inc. (TOPS) Q2 2026: Revenue Decline, Net Income Drops — Disappointing In the second quarter of 2026, TOP Ships Inc. reported a significant decline in revenue, with total revenues falling to $25.5 million, a decrease of $18.3 million or -42% compared to the same period in 2025. This sharp...
LuxExperience (LUXE) Q4 2026 Financial Results
LuxExperience (LUXE) Q4 FY26: Strong Net Sales Growth and Profitability Improvement — Positive Outlook In its fourth quarter of fiscal year 2026, LuxExperience B.V. reported a robust performance with net sales increasing by €653.6 million, reflecting a growth of +6.1% year-over-year (YoY). When...
S&P 500 2026 YTD Highs & Lows Radar: Chevron (CVX), TJXmpanies, (TJX) and more
S&P 500 stocks nearest to their 2026 year-to-date high and low. Bloomberg-style charts, RSI/MA analysis and Grok commentary.
HeartSciences (HSCS) FQ1 2027 Financial Results Summary
HeartSciences (HSCS) Q1 2027: Revenue Miss, Losses Widen — Cautiously Disappointing HeartSciences Inc. (Nasdaq: HSCS) reported its fiscal first quarter 2027 financial results, revealing a disappointing performance compared to the previous year. The company reported no meaningful revenue for the...
Ispire Technology (ISPR) Q3 2026 Financial Results Summary
Ispire Technology Inc. (ISPR) Q3 2026: Leadership Change to Enhance Investor Relations — Positive Outlook Ispire Technology Inc. (NASDAQ: ISPR) has announced a significant leadership change with the appointment of Steven Przybyla as President, effective immediately. This move is aimed at...